B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Icotinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Icotinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

whi
5 shared targets
cudc
6 shared targets
dacomitinib
3 shared targets
osimertinib
3 shared targets
lapatinib
4 shared targets
gsk
4 shared targets
varlitinib
2 shared targets
sapitinib
3 shared targets
ribociclib
2 shared targets
sgi
3 shared targets
Loading evidence profile...

This evidence profile for Icotinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.